These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15272242)
1. Markers of beta cell function in type 1 diabetes mellitus. Vendrame F; Zappaterreno A; Dotta F Minerva Med; 2004 Apr; 95(2):79-84. PubMed ID: 15272242 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus. Torella R; Salvatore T; Cozzolino D; Grandillo F; Giugliano D Acta Diabetol Lat; 1988; 25(2):161-72. PubMed ID: 3146849 [TBL] [Abstract][Full Text] [Related]
3. Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population. Gürlek A; Erbaş T; Sayinalp S; Gedik O Acta Diabetol; 1996 Sep; 33(3):216-9. PubMed ID: 8904928 [TBL] [Abstract][Full Text] [Related]
4. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes. Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of beta cell failure after prolonged remission of insulin-dependent diabetes mellitus (IDDM). Drucker D; Zinman B Diabetes Care; 1984; 7(1):83-7. PubMed ID: 6423354 [TBL] [Abstract][Full Text] [Related]
6. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218 [TBL] [Abstract][Full Text] [Related]
7. B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus. Heaton DA; Lazarus NR; Pyke DA; Leslie RD Diabetologia; 1989 Nov; 32(11):814-7. PubMed ID: 2687066 [TBL] [Abstract][Full Text] [Related]
8. C-peptide: an index of insulin secretion. Faber OK; Binder C Diabetes Metab Rev; 1986; 2(3-4):331-45. PubMed ID: 3527619 [TBL] [Abstract][Full Text] [Related]
9. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells]. Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807 [TBL] [Abstract][Full Text] [Related]
10. [LADA--latent autoimmune diabetes in adults]. Szelachowska M Endokrynol Pol; 2007; 58(3):246-51. PubMed ID: 17940991 [TBL] [Abstract][Full Text] [Related]
11. Metabolic tests to determine risk for type 1 diabetes in clinical trials. Greenbaum CJ; Buckingham B; Chase HP; Krischer J; Diabetes Metab Res Rev; 2011 Sep; 27(6):584-9. PubMed ID: 21488143 [TBL] [Abstract][Full Text] [Related]
12. Young Chinese adults with new onset of diabetic ketoacidosis--clinical course, autoimmune status and progression of pancreatic beta-cell function. Li JK; Chan JC; Zimmet PZ; Rowley MJ; Mackay IR; Cockram CS Diabet Med; 2000 Apr; 17(4):295-8. PubMed ID: 10821296 [TBL] [Abstract][Full Text] [Related]
13. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
14. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus. Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919 [TBL] [Abstract][Full Text] [Related]
15. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Scheen AJ; Castillo MJ; Lefèbvre PJ Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of type 1 diabetes mellitus in Taiwanese children aged younger than 6 years: A single-center experience. Chen YC; Tung YC; Liu SY; Lee CT; Tsai WY J Formos Med Assoc; 2017 May; 116(5):340-344. PubMed ID: 27521183 [TBL] [Abstract][Full Text] [Related]
17. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Björk E; Berne C; Kämpe O; Wibell L; Oskarsson P; Karlsson FA Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981 [TBL] [Abstract][Full Text] [Related]
18. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus. Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100 [TBL] [Abstract][Full Text] [Related]
19. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Palmer JP; Fleming GA; Greenbaum CJ; Herold KC; Jansa LD; Kolb H; Lachin JM; Polonsky KS; Pozzilli P; Skyler JS; Steffes MW Diabetes; 2004 Jan; 53(1):250-64. PubMed ID: 14693724 [TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness. Amoah AG; Owusu SK; Schuster DP; Osei K S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]